Cigna Group $CI Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in Cigna Group (NYSE:CI) by 7.1% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 643,370 shares of the health services provider’s stock after buying an additional 42,401 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.24% of Cigna Group worth $177,364,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of CI. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter valued at approximately $25,000. Cedar Mountain Advisors LLC raised its stake in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new stake in Cigna Group during the 4th quarter worth about $29,000. Prosperity Bancshares Inc purchased a new stake in shares of Cigna Group in the fourth quarter valued at $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Cigna Group during the 2nd quarter worth about $34,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Down 2.7%

Shares of NYSE CI opened at $275.03 on Tuesday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market cap of $72.67 billion, a P/E ratio of 11.38, a P/E/G ratio of 0.97 and a beta of 0.29. The firm has a 50 day moving average price of $285.73 and a 200 day moving average price of $281.32.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the prior year, the company earned $7.20 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Wall Street Analysts Forecast Growth

CI has been the subject of several recent analyst reports. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Mizuho upped their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Piper Sandler dropped their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.